Your browser is no longer supported. Please, upgrade your browser.
Settings
GWPH GW Pharmaceuticals plc daily Stock Chart
GWPH [NASD]
GW Pharmaceuticals plc
Index- P/E- EPS (ttm)-8.90 Insider Own0.62% Shs Outstand31.18M Perf Week-7.66%
Market Cap4.81B Forward P/E- EPS next Y-1.91 Insider Trans-94.63% Shs Float2.25M Perf Month-7.12%
Income-261.80M PEG- EPS next Q-1.68 Inst Own80.60% Short Float- Perf Quarter-11.92%
Sales47.70M P/S100.79 EPS this Y78.50% Inst Trans-0.49% Short Ratio- Perf Half Y2.46%
Book/sh20.76 P/B7.43 EPS next Y59.20% ROA- Target Price227.08 Perf Year16.33%
Cash/sh16.73 P/C9.22 EPS next 5Y- ROE- 52W Range90.14 - 196.00 Perf YTD58.32%
Dividend- P/FCF- EPS past 5Y-22.00% ROI-10.40% 52W High-21.33% Beta2.24
Dividend %- Quick Ratio7.20 Sales past 5Y-26.00% Gross Margin78.70% 52W Low71.06% ATR5.86
Employees791 Current Ratio7.80 Sales Q/Q2093.60% Oper. Margin- RSI (14)39.83 Volatility3.26% 3.35%
OptionableYes Debt/Eq0.00 EPS Q/Q26.90% Profit Margin- Rel Volume0.70 Prev Close152.92
ShortableYes LT Debt/Eq0.01 EarningsAug 06 AMC Payout- Avg Volume392.64K Price154.19
Recom1.60 SMA20-4.20% SMA50-8.16% SMA2000.30% Volume274,761 Change0.83%
May-07-19Upgrade Oppenheimer Perform → Outperform
May-07-19Reiterated Guggenheim Buy $186 → $222
May-07-19Reiterated Cantor Fitzgerald Overweight $196 → $229
Mar-18-19Reiterated Cantor Fitzgerald Overweight $193 → $196
Jan-02-19Initiated JP Morgan Overweight $134
Nov-05-18Resumed Piper Jaffray Overweight
Sep-28-18Reiterated BofA/Merrill Buy $181 → $197
Sep-07-18Resumed Morgan Stanley Overweight
Aug-15-18Initiated Stifel Buy $181
Aug-08-18Reiterated Cantor Fitzgerald Overweight $235 → $211
Apr-19-18Reiterated Cantor Fitzgerald Overweight $192 → $205
Feb-06-18Reiterated Cantor Fitzgerald Buy $208 → $192
Dec-14-17Upgrade Goldman Neutral → Buy
Oct-06-17Resumed Goldman Neutral
Aug-17-17Initiated Evercore ISI Outperform $154
Aug-08-17Downgrade Maxim Group Buy → Hold
Apr-21-17Initiated Maxim Group Buy $135
Dec-05-16Reiterated Cantor Fitzgerald Buy $182 → $208
Oct-07-16Initiated Goldman Buy
Oct-04-16Resumed Leerink Partners Outperform $162
Aug-17-19 11:04AM  Better Buy: GW Pharmaceuticals vs. Amarin Motley Fool
Aug-15-19 10:18AM  Early Success Of CBD Drug Looms Large For The Industry's Future Benzinga
07:22AM  GW Pharmaceuticals, NetApp, KB Home, PulteGroup, M/I Homes, Lennar and Toll Brothers highlighted as Zacks Bull and Bear of the Day Zacks
05:16AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Aug-14-19 09:38AM  HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day Zacks
09:15AM  Market Takes Off After Tariffs Pushed Back Zacks
06:33AM  3 Cannabis Stocks With the Fastest-Growing Sales Motley Fool
Aug-13-19 10:34AM  Tilray to Report Earnings Today: Will It Top or Flop? Zacks
Aug-12-19 06:17PM  Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF Zacks
04:47PM  Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF Zacks
12:37AM  Weekly Cannabis Stock News: GW Pharmaceuticals Blows Past Estimates Motley Fool
Aug-11-19 02:46PM  The Week In Cannabis: CannTrust Rallies Unexpectedly, Josh Kushner And Shane Victorino Join The Industry, And More Benzinga
Aug-10-19 05:15PM  Marijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring MarketWatch
Aug-09-19 03:16PM  Edited Transcript of GWPH.O earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
02:47PM  GW Pharmaceuticals (GWPH) Q2 2019 Earnings Call Transcript Motley Fool
Aug-08-19 03:36PM  Cronos Group's Q2 Trounces Estimates Motley Fool
01:16PM  Cramer: Epidiolex Maker GW Pharma Is Far From A 'Sketchy' Weed Business Benzinga
09:39AM  6 Positive Catalysts to Drive GW Pharmaceuticals (GWPH) Stock Further TipRanks
08:31AM  The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It TheStreet.com
06:07AM  3 Pot Stocks With Rising Profit Projections Motley Fool
Aug-07-19 11:47AM  GW Pharma Analysts Raise Estimates After CBD Drug Epidiolex Shows Strong Uptake Benzinga +9.15%
11:05AM  9 High-Risk Stocks to Buy for Massive Rewards InvestorPlace
11:04AM  GW Pharmaceuticals Q2 Results Crush Revenue Estimates; Stock Soars Motley Fool
07:34AM  The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout Benzinga
06:05AM  [video]GW Pharma Surges on Marijuana-Based Epilepsy Drug Sales, Analyst Upgrades TheStreet.com
Aug-06-19 09:30PM  3 Things You'll Want to Know About GW Pharmaceuticals' Sizzling Q2 Results Motley Fool
04:49PM  Biotech Stock Pops Higher Alongside Demand For Cannabis Medicine Investor's Business Daily
04:16PM  GW Pharma Stock Rockets As Cannabis Medicine Sales Crush Views Investor's Business Daily
04:08PM  GW Pharma Rallies On Strong Q2 Epidiolex Sales, Says European Approval Expected In October Benzinga
04:01PM  GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019 GlobeNewswire
11:47AM  3 Marijuana Stocks to Play the Future of Cannabis Medicine InvestorPlace
Aug-05-19 08:13AM  The Week Ahead In Cannabis: Cronos And GW Pharma Earnings, Ontario's Second License Lottery Benzinga
Aug-02-19 01:36PM  GWPH Stock: Expect the Unexpected Coming Into Earnings InvestorPlace
12:46PM  FDA Can't Figure Out How To Regulate CBD - And It Doesn't Really Want To Benzinga
09:15AM  New Tariff Threat Ends Rebound Rally Zacks
Aug-01-19 09:30AM  Is GW Pharmaceuticals (GWPH) Outperforming Other Medical Stocks This Year? Zacks
Jul-31-19 11:14AM  Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings? Zacks
Jul-30-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Dips More Than Broader Markets: What You Should Know Zacks
04:11PM  What To Know About The Senate Hearing On Hemp Benzinga
11:53AM  Can GW Pharmaceuticals (GWPH) Deliver a Beat in Q2 Earnings? Zacks
10:22AM  4 Medical Product Stocks Set to Beat This Earnings Season Zacks
Jul-29-19 08:33PM  How this East Bay biotech moved from an 'error' to a potential treatment for kids with severe seizures American City Business Journals
08:21AM  The FDA Just Showed Its Hand on CBD -- Is It Time for Investors to Fold? Motley Fool
Jul-28-19 03:51PM  The Week In Cannabis: Tobacco And Retail Stray In The Weeds, Congress Holds SAFE Banking Hearings, New ETFs, And More Benzinga
09:06AM  The 13 Largest Marijuana Stocks in the World Motley Fool
Jul-26-19 04:26PM  This Biotech Stock Flew Higher On Likely CBD Oil Approval in Europe Investor's Business Daily
03:09PM  Marijuana & Blockchain ETFs: Should You Buy? Zacks
12:58PM  European Medicines Agency gives positive opinion on GW Pharma's cannibidiol drug MarketWatch
10:48AM  GW Pharma Receives EU Regulatory Agency Panel Backing For Epidiolex Benzinga
09:16AM  UPDATE 1-European panel okays GW Pharma cannabis drug for epilepsy Reuters
07:48AM  GW Pharma cannabis drug wins European panel OK Reuters
06:46AM  GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy GlobeNewswire
Jul-24-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Gains But Lags Market: What You Should Know Zacks
02:15PM  Inside the New Amplify Cannabis ETF ETF Trends
12:33PM  Illumina, GW Pharmaceuticals, Paycom, Zscaler and Square highlighted as Zacks Bull and Bear of the Day Zacks
06:45AM  Bull of the Day: GW Pharmaceuticals (GWPH) Zacks
Jul-23-19 01:27PM  GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending June 30, 2019 and Host Conference Call on August 6, 2019 GlobeNewswire
09:42AM  Zynerba Pharma Looks Like Bad Medicine for Investors TheStreet.com
07:41AM  Jim Cramer Weighs In On Berkshire Hathaway, Range Resources, Zynerba And More Benzinga
Jul-19-19 07:51AM  Don't Hold Your Breath for the FDA's CBD Report Motley Fool
Jul-18-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
Jul-17-19 11:37AM  6 Cannabis Market Predictions That Are Already Coming True Benzinga
Jul-16-19 07:46AM  Cannabis stocks rally after FDA says it will speed up effort to create rules for CBD MarketWatch
Jul-15-19 09:52AM  Scott's Miracle Grow's, ADT, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day Zacks
09:30AM  Is GW Pharmaceuticals (GWPH) Outperforming Other Medical Stocks This Year? Zacks
Jul-12-19 06:07PM  Cronos to Acquire Apotex's Manufacturing Plant in Winnipeg Zacks
05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
05:37PM  Legal Cannabis Faces Competition from Black Market: 3 Stocks That Can Lead the Brigade Zacks
Jul-10-19 05:20PM  CannTrust Falls as Health Canada Issues Non-Compliance Report Zacks
11:32AM  The Zacks Analyst Blog Highlights: GW, Scotts Miracle-Gro, Cronos, CannTrust and Canopy Zacks
Jul-09-19 04:03PM  Cannabis stocks dragged down by CannTrusts losses after cannabis seizure MarketWatch
10:17AM  An Examination Of GW Pharmaceuticals plc (NASDAQ:GWPH) Simply Wall St.
08:35AM  5 Picks Ahead of Key Congressional Hearing on Marijuana Laws Zacks
Jul-08-19 06:29PM  Here's Why Zogenix Leaped 26.8% in June Motley Fool
Jul-07-19 02:11PM  The Week In Cannabis: Canopy Growth Trims Bruce Linton, Congressional Hearings On Ending Marijuana Prohibition, And More Benzinga
11:21AM  Why Marijuana Stock GW Pharmaceuticals Soared 77% in the First Half of 2019 Motley Fool
11:19AM  5 Stocks With Over 20% Upside Potential, Say Top Analysts TipRanks
Jul-03-19 01:15PM  Cannabis Stocks With Plenty Of Green Ahead Benzinga
08:15AM  5 Best Cannabis Stocks of 2019 So Far -- Are They Buys Now? Motley Fool
Jul-02-19 07:16AM  Better Buy: GW Pharmaceuticals vs. Cara Therapeutics Motley Fool
Jul-01-19 05:01PM  Why Medicare for all could 'dramatically' increase access to medical marijuana Yahoo Finance
08:21AM  The Best Marijuana Stocks in the First Half of 2019 Motley Fool
Jun-29-19 07:00AM  Better Cannabis Stock: OrganiGram Holdings vs. GW Pharmaceuticals Motley Fool
Jun-28-19 03:51PM  Meet The 3 Biggest Industries Investing In Cannabis Benzinga
11:25AM  Zacks.com featured highlights include: GW, CGI and Bloom Energy Zacks
09:30AM  Has GW Pharmaceuticals (GWPH) Outpaced Other Medical Stocks This Year? Zacks
Jun-27-19 05:50PM  GW Pharmaceuticals PLC (GWPH) Outpaces Stock Market Gains: What You Should Know Zacks
08:41AM  3 of the Best Stocks With Superb Earnings Acceleration Zacks
08:00AM  Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer GlobeNewswire
Jun-26-19 03:57PM  But, Which Spectrum? What You Need To Know About Hemp And Its Chemical Compounds Benzinga
02:12PM  Money flows in 17 popular marijuana stocks show fewer short squeezes MarketWatch
Jun-25-19 08:25AM  The Zacks Analyst Blog Highlights: Canopy Growth, GW, Scotts Miracle-Gro, Cronos and Aurora Zacks
07:21AM  The Surprising Pot Stock Forecast to Lead the Industry in 2020 Sales Motley Fool
Jun-24-19 08:41AM  Breakthrough in U.S. Marijuana Industry: 5 Likely Gainers Zacks
Jun-23-19 03:12PM  The Week In Cannabis: House Takes Historic Vote, New York Decriminalizes, Woman-Led Company Lists On Nasdaq, And More Benzinga
08:00AM  The Most Important Marijuana Growth Chart You'll Ever See Motley Fool
Jun-22-19 10:01PM  Is CBD Bad for Your Liver? The Shocking Findings of 1 New Study Motley Fool
Jun-20-19 05:45PM  GW Pharmaceuticals PLC (GWPH) Stock Sinks As Market Gains: What You Should Know Zacks
08:34AM  BDS Analytics, Arcview Project $40B In Global Cannabis Spending By 2024 Benzinga
07:36AM  Opinion: Medical Marijuana Is a Terrible Investment Motley Fool
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. Its lead product is Epidiolex, an oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of glioblastoma, neonatal hypoxic-ischemic encephalopathy, and schizophrenia. Further, the company has license and development agreements with Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United Kingdom, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Snyder Douglas B.Chief Legal OfficerAug 12Sale13.883,75652,13379,164Aug 14 05:30 PM
Waldegrave William A.DirectorJul 10Option Exercise0.003,57653,576Jul 11 09:00 PM
Waldegrave William A.DirectorJul 10Sale15.003,57653,6400Jul 11 09:00 PM
Snyder Douglas B.Chief Legal OfficerJul 09Sale14.424,96871,63982,920Jul 11 09:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Option Exercise3.2464,800209,95267,303Jun 05 08:00 PM
Tovey Christopher J.Chief Operating OfficerJun 03Sale14.6164,800946,7282,503Jun 05 08:00 PM
Gover Justin D.Chief Executive OfficerMay 28Option Exercise0.00202,224263743,765May 30 08:00 PM
Gover Justin D.Chief Executive OfficerMay 28Sale15.24202,2243,081,804541,541May 30 08:00 PM
Noble JamesDirectorMay 24Option Exercise4.0182,596331,347110,096May 29 08:00 PM
Noble JamesDirectorMay 24Sale15.3282,5961,265,08327,500May 29 08:00 PM
Knappertz VolkerChief Medical OfficerMay 20Sale14.6412,144177,84685,824May 21 08:00 PM
Giacobello Scott M.Chief Financial OfficerMay 20Sale14.524,22461,33287,096May 21 08:00 PM
Knappertz VolkerChief Medical OfficerMay 18Option Exercise0.0012,1441697,968May 21 08:00 PM
Giacobello Scott M.Chief Financial OfficerMay 18Option Exercise0.008,1361191,320May 21 08:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Option Exercise3.291,2003,9483,703May 17 07:00 PM
Tovey Christopher J.Chief Operating OfficerMay 15Sale15.011,20018,0122,503May 17 07:00 PM
Gangolli Julian SPresident, North AmericaMay 10Option Exercise2.26671,9281,517,239778,476May 14 09:00 PM
Gangolli Julian SPresident, North AmericaMay 10Sale14.84671,9289,973,283106,548May 14 09:00 PM
Tovey Christopher J.Chief Operating OfficerMay 07Option Exercise0.00200,736261203,239May 09 08:01 PM
George Adam D.SecretaryMay 07Option Exercise0.00258,324336268,324May 09 08:04 PM
George Adam D.SecretaryMay 07Sale16.10258,3244,159,01610,000May 09 08:04 PM
Tovey Christopher J.Chief Operating OfficerMay 07Sale16.14200,7363,239,8792,503May 09 08:01 PM
Gover Justin D.Chief Executive OfficerMar 15Option Exercise0.0047,85162564,960Mar 19 07:00 PM
Gover Justin D.Chief Executive OfficerMar 15Sale14.0123,400327,834541,541Mar 19 07:00 PM
MACKEY CATHERINE JDirectorMar 13Sale14.3988812,77819,284Mar 15 09:15 PM
Secor AliciaDirectorMar 13Sale14.2090012,78019,272Apr 12 05:30 PM
GUY GEOFFREY W DRExecutive ChairmanMar 04Sale14.75900,00013,275,0008,141,521Mar 05 09:05 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Option Exercise1.07576,000618,5099,041,521Mar 05 09:05 PM
Brown CabotDirectorMar 01Option Exercise3.5548,540172,21855,740Mar 05 09:09 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.38576,0008,281,2358,465,521Mar 01 08:01 PM
Brown CabotDirectorMar 01Sale14.3852,104749,0463,636Mar 05 09:09 PM
Knappertz VolkerChief Medical OfficerMar 01Sale14.463,73253,9658,736Mar 05 09:06 PM
GUY GEOFFREY W DRExecutive ChairmanMar 01Sale14.49300,0004,347,000103,925Mar 05 09:05 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Option Exercise0.0010,4041415,768Feb 28 05:00 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Option Exercise0.009,612129,612Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 26Option Exercise0.0022,44029392,885Feb 28 05:02 PM
Knappertz VolkerChief Medical OfficerFeb 26Option Exercise0.008,4361116,608Feb 28 05:05 PM
Gangolli Julian SPresident, North AmericaFeb 26Option Exercise0.0011,25615112,548Feb 28 05:09 PM
Gangolli Julian SPresident, North AmericaFeb 26Sale12.456,00074,696106,548Feb 28 05:09 PM
Knappertz VolkerChief Medical OfficerFeb 26Sale12.464,14051,56812,468Feb 28 05:05 PM
Gover Justin D.Chief Executive OfficerFeb 26Sale12.4511,112138,328381,773Feb 28 05:02 PM
Snyder Douglas B.Chief Legal OfficerFeb 26Sale12.434,64457,7034,968Feb 28 05:00 PM
Giacobello Scott M.Chief Financial OfficerFeb 26Sale12.455,23265,12410,536Feb 28 05:00 PM
Gover Justin D.Chief Executive OfficerFeb 13Sale12.5022,620282,750370,445Feb 15 04:31 PM
Secor AliciaDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:23 PM
Brown CabotDirectorJan 03Option Exercise0.003,580523,808Mar 15 09:16 PM
MACKEY CATHERINE JDirectorJan 03Option Exercise0.003,580520,172Mar 15 09:15 PM
Gover Justin D.Chief Executive OfficerJan 02Sale8.3322,620188,407393,065Jan 04 04:15 PM
Gover Justin D.Chief Executive OfficerDec 20Option Exercise0.0045,24059415,685Dec 26 04:15 PM
George Adam D.SecretaryNov 21Option Exercise0.0010,0001310,000Nov 23 04:30 PM